Lake Forest, Ill.-based generic eye care product developer Akorn has purchased Amityville, N.Y.-based Hi-Tech Pharmacal for $640 million in cash and loans.
Akorn will now expand its product line into cold and cough treatments. The company's combined annual revenue will be more than $500 million.
More Articles on Ophthalmology:
Aurora Eye Care in Ohio Adds Optician Brenda Nemec
Heaton Eye Associates in Longview Relocates Office
Mayo Clinic Arizona Adopts Light Therapy Chronic Dry Eye Treatment